Spectoceutics ApS
CVR 44427923 · Private limited company (ApS) · Active · Low risk
Spectoceutics ApS is a Private limited company (ApS), founded on , based in Gentofte. The company is registered in the industry forskning og eksperimentel udvikling inden for naturvidenskab og teknik. Our model estimates a bankruptcy risk of 0.2% over the next 12 months, which is 0.2 times the average for Danish companies. 2 annual reports have been published. The latest annual report (31 Dec 2025) shows equity of DKK 19k and a net result of DKK -14k. CEO: Carsten Højer.
Bankruptcy risk for Spectoceutics ApS
0.2 × the average (1.41%) · higher risk than 49% of active Danish companies
Increases the risk
Reduces the risk
The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.
Company details
- CVR number
- 44427923
- Status
- Active
- Company type
- Private limited company (ApS)
- Founded
- (2 years)
- Address
- Solbakkevej 37A
2820 Gentofte - Municipality
- Gentofte
- Industry
- Forskning og eksperimentel udvikling inden for naturvidenskab og teknik (721000)
Bankruptcies in the industry: Anden forskning og eksperimentel udvikling inden for naturvidenskab og teknik - Share capital
- DKK 40k
- Audit opted out
- Yes
Warning signs
| Annual reports filed late | 0 of 2 |
| Missing annual report | No |
| Negative equity | No |
| Equity ratio | 96.9% |
| Current ratio | 3,258% |
| Moves (last 2 years) | 0 |
| CEO changes in total | 0 |
| CEO's previous bankruptcies | 0 |
| Other companies at the address | 8 |
| Going-concern uncertainty | No |
Financials and key figures
| Financial year | 2025 | 2024 |
|---|---|---|
| Gross profit | DKK -17k | DKK -7,043 |
| Net profit | DKK -14k | DKK -7,048 |
| Equity | DKK 19k | DKK 33k |
| Total assets | DKK 20k | DKK 34k |
| Cash | DKK 16k | – |
| Short-term debt | DKK 615 | – |
| Tax owed | DKK 0 | – |
Latest annual report: Reporting class B, mikrovirksomhed · auditor's statement: No assurance.
Filed annual reports
| Reporting period | Published | Days after period end | |
|---|---|---|---|
| 1 Jan 2025 – 31 Dec 2025 | 180 | ||
| 9 Nov 2023 – 31 Dec 2024 | 181 |
The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.
Management, owners and auditor
| Role | Name | From | To |
|---|---|---|---|
| CEO | Carsten Højer | Current | |
| Owner (5%) | Anders Ohlhues Baandrup | Current | |
| Owner (90%) | Dunnock Holding ApS | Current | |
| Founder | Anders Ohlhues Baandrup | Current | |
| Founder | Dunnock Holding ApS | Current |
The CEOs' other companies
Carsten Højer – 6 other companies
- AMPLIQON A/S Active
- CS PRO Global ApS Opløst
- DB LAB A/S Active
- DB LAB HOLDING A/S Opløst
- Dunnock Holding ApS Active
- SHAREWORKERS ApS Active
Address history (0 moves)
| Solbakkevej 37A, 2820 Gentofte |
Other companies at the same address
- CS PRO Global ApS Opløst
- DELEURAN HOLDING ApS Opløst
- Dunnock Holding ApS Active
- O. BJØRN-JENSEN & CO. ApS Opløst
- SHAREWORKERS ApS Active
- TD HOLDING 2013 ApS Opløst
- VISIONPRO ApS Opløst
- VISIONPRO SUPPLY ApS Opløst
Similar companies in Gentofte
- Lica Pharma ApS Hellerup
- SKN computation ApS Gentofte
- WinQure Medicine ApS Klampenborg
- Illum Biotech ApS Charlottenlund
- Novo Nordisk Clinical Innovation Centre A/S Gentofte
- Bollværk ApS Hellerup
- Epitopea ApS Klampenborg
- CENEXUM Technologies ApS Gentofte
- Protein Frontiers ApS Gentofte
- ClinOption ApS Dyssegård
- Ascendis Pharma Oncology Division A/S Hellerup
- Merian Life Sciences ApS Hellerup
Questions and answers about Spectoceutics ApS
Has Spectoceutics ApS gone bankrupt?
No, Spectoceutics ApS is not registered as bankrupt in the CVR register. Its status is: active.
What is the bankruptcy risk of Spectoceutics ApS?
Our model estimates a bankruptcy risk of 0.2% over the next 12 months (low risk), which is 0.2 times the average for Danish companies.
Who is the CEO of Spectoceutics ApS?
Carsten Højer is the CEO of Spectoceutics ApS.
When was Spectoceutics ApS founded?
Spectoceutics ApS was founded on 9 November 2023.
What is the equity of Spectoceutics ApS?
Equity was DKK 19k according to the annual report for the period ending 31 December 2025.
Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.